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Administration of PRN Medications by the Nurse to Incapacitated Patients: An Ethical 
Perspective  
Abstract 
The administration of pro re nata (PRN) medications is the responsibility of the nurse. However, 
ethical uncertainties often happen due to the inability of incapacitated patients to collaborate 
with the nurse in the process of decision-making for PRN medication administration. There is 
a lack of integrative knowledge and insufficient understanding regarding ethical considerations 
surrounding the administration of PRN medications to incapacitated patients. Therefore, they 
have been discussed in this paper and practical strategies to avoid unethical practices have been 
suggested. The complicated caring situation surrounding the administration of PRN 
medications is intertwined with ethical issues affecting the consideration of the patient’s wishes 
and interventions that override them. The patient’s right of autonomy and treatment refusal, 
surrogacy role, paternalism, and coercion are the main ethos of ethical PRN medication 
administration. Education and training can help nurses avoid legal and ethical issues in PRN 
medicines management and improve the quality and safety of health care. Empirical research 
is needed to improve our understanding of this phenomenon in the multidisciplinary 
environment of medicines management. 
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Introduction 
A medication error is defined as “an avoidable adverse effect of healthcare, whether or not it is 
obvious or harmful to the patient something incorrectly done through ignorance or inadvertence; 
a mistake, e.g., miscalculation, judgment, speech, writing, action, or a failure to complete a 
planned action as intended, or the use of an incorrect plan of action to achieve a given aim” (p. 
6013) 1. Medication administration error is a high-risk situation during medicines management 
and with a median of 8.0% is the primary cause of medication harm. It is characterised by errors 
in the timing, omitted, and wrong doses of medication in various healthcare conditions and age 
groups 2, 3. A multicentre study in 38 hospitals in the UK on the prevalence, nature, and 
predictors of medication administration omissions using the MedsST tool indicated that 
medication administration omission was frequent and was influenced by the number of 
administered medications to patients 4. Therefore, the safety of medication administration is 
one of the most important initiatives for the improvement of patient safety in the healthcare 
system. The WHO has estimated that the global cost of medication errors would be 42 billion 
USD annually 5 and the Third Global Patient Safety Challenge on ‘Medication without harm’ 
has discussed issues and strategies to reduce harm associated with the medication process in 
high-risk healthcare situations 5, 6.   
The application of multidisciplinary and collaborative strategies by physicians, pharmacists, 
and nurses can enhance the safety of medicines management 7. In this respect, the 
administration of medications is the primary role of nurses with an undeniable impact on patient 
safety  8, 9. Nurses are trained and authorized to prepare medications, calculate doses, administer, 
and monitor medications’ side effects and adverse drug reactions 10-12. Safe administration of 
medications requires nurses to use their theoretical knowledge and clinical skills during the 
medication process 13, 14. The ‘rights of medication administration’ as patient, drug, route, dose, 
time, documentation, and reason have been recognized as traditionally important tools in the 
hands of nurses to ensure the safety of medication administration 15.   
PRN Medication Administration by the Nurse 
“Pro re nata” (PRN) medication administration is a main responsibility of nurses and has been 
described as the administration of medications based on the patient’s immediate need instead 
of administration at predetermined times 16, 17. After the prescription of PRN medications by 
the physician, the nurse makes a collaborative decision with participation of the patient 
regarding medication administration 17, 18. PRN medicines management has been recognized by 
international healthcare associations as an appropriate method for the management of physical 
and psychological suffering among patients with acute and chronic healthcare conditions 19-21.   
Prescription and administration of PRN medications have become a main part of medicines 
management in various healthcare settings. For instance, 90%, of patients with mental and 
psychiatric health conditions and 20-86% of residents in nursing homes are prescribed at least 
one PRN medication 22-24. The exact number of medication errors due to PRN medication 
administration has not been reported in the international literature. PRN medication errors are 
characterized by not mentioning the reason behind medication administration and ambiguities 
in steps taken to manage the administration process, as well as to monitor their effects and side 
effects after administration 25, 26. Coercion in the administration 27, and over-administration of 
PRN medications, when medication is not the first choice for treatment 18, 28 are quite common. 
Inappropriate use of PRN medications is associated with polypharmacy and longer stays in 
nursing homes with a median of 2.1 years 29.  
The safety of medicines management is intertwined with ethical nursing practice 30, 31. Nurses 
are professionally obliged to administer medications in a manner that is consistent with ethical 
codes for practice as ‘do the good and right thing for patients’, prevent harm, and evaluate the 
probable outcomes of medication administration interventions 32-34. Insufficient knowledge of 
ethical considerations influencing all types of medication administration including PRN 
medications has become the source of moral distress in nurses 35, their burn-out and job turnover 
36. 
Decision Making for Care by Incapacitated Patients   
Temporary or permanent physical and psychological incapacity during each person’s life is 
common. Over one billion people, that is about 15% of the world population, live with some 
form of disability and incapacity and an increasing trend is captured in this figure 37. 
Incapacitated patients often suffer from severe mental or physical conditions to the extent that 
they have no sufficient understanding required for making or communicating responsible 
healthcare decisions 38, 39. With a capacity to make decisions, the patient should have the ability 
to understand the meaning of the information provided by healthcare staff, can connect them to 
their healthcare situation, use the information to decide, and communicate their choice and 
preferences regarding therapeutic measures 40, 41. 
Incapacitated patients can be older people and mentally ill that have been described as highly 
vulnerable patients in the healthcare literature 42. They sometimes have no friends or family to 
make medical decisions as default surrogates 43.  
According to the Convention on the Rights of Persons with Disabilities (CRPD) by the United 
Nations (UN), patients with any sort of disability and incapacity have the right to benefit from 
appropriate decisions made on their lives 44. Making appropriate decisions with regard to 
healthcare and therapeutic measures influence the patient’s wellbeing. If the patient has no 
capacity to make decisions, family members and healthcare providers can be authorised to make 
decisions on their behalf 45.  
Decision-making for incapacitated patients who cannot make decisions for themselves is 
considered a common concern for healthcare providers and is often intertwined with ethical 
issues 46, given that the patient’s informed consent is a prerequisite for all types of healthcare 
interventions. Nevertheless, interventions that are in the interest of such incapacitated patients 
and when the interventions are accompanied with a minimum risk and burden are exempt from 
this rule 47. Having no capacity to decide imposes high levels of care burden on healthcare 
providers especially when medications are prescribed and administered, and in case that patient 
refuses to undertake healthcare procedures 48-50. This situation is also accompanied by various 
ethical complexities affecting the society and healthcare staff individually 51, 52.  
PRN Medicines Management for Incapacitated Patients 
PRN medicines management generally is the process of creating a mutual understanding and 
the feeling of responsibility between the nurse and the patient in order to choose the most 
effective medication with the lowest possibility of side effects and adverse drug reactions 14, 17. 
However, the requirements for making bilateral decisions by the nurse and the patient may not 
be achieved given the patient’s incapacity to understand and actively take part in the medication 
process as a member of the healthcare team 53-55. This situation creates barriers to ethical 
decision making by clinical nurses and can be the ground for the development of ethical 
dilemma.  
Given the lack of integrative knowledge and insufficient understanding of ethical challenges 
surrounding the administration of PRN medications to incapacitated patients, the question is: 
how nurses can avoid unethical practice in PRN medicines management for these patients?   
Ethics of Administration of PRN Medications to Incapacitated Patients 
The nurse is obliged to play the role of the patient’s advocate and put the patient’s individual 
preferences and wishes at the centre for making the decision to administer PRN medications. 
However, in some situations the healthcare professional’s wishes override those of the patients 
to benefit the patient and prevent harm. The ethical problem is raised in the preservation of the 
right to accept or refuse receiving medications given the patient’s right of autonomy. Respect 
for the patient’s autonomy requires to recognize his/her right to decide about own treatment and 
to refuse receiving treatment in case that the patient understands the action and is not forced to 
comply with the action 56-58.  
Complying with the patient’s wishes  
Some patients such as nonverbal trauma patients or those with severe mental and cognitive 
impairments may have no or very limited decision-making capacity. Therefore, they may be 
unable to understand the reason for PRN medication administration and collaborate in the 
related process. Therefore, being the patient’s representative or taking the surrogacy role to 
predict therapeutic needs for such incapacitated patients is needed. A suggested solution is the 
involvement of patients’ families for the prediction of their preferences during the periods of 
incapacity and to receive treatments that comply with their own needs and wishes 59, 60. Family 
members are appropriate sources to find the most suitable treatment and care modality 61, 
because they can better guess the patient’s preferences in similar circumstances and how their 
needs can be met 62. Family members also can play the role of the patient’s surrogate and the 
essential partner for making decisions on the patient’s behalf and can share the responsibility 
of decision making with nurses. This approach to decision-making can prevent moral and 
emotional distress in clinical nurses and enhance trust and consensus between healthcare 
professionals and family members 63.  
Making decisions to perform any sort of medical interventions including the administration of 
PRN medications to incapacitated patients who have no family members to take the surrogate 
role is also complicated and is filled by ambiguities 64. Therefore, obtaining consent to start the 
medical procedure for these patients is intertwined with ethical issues and the patient's right 
problem 43. If it is not resolved by the healthcare team, an ethical dilemma may occur given its 
impact on the patient’s care outcome 65. As if it is not a perfect solution, the use of clinical 
guidelines and a three-step approach of the physician, ethics committee, and guardian have been 
suggested 64. The essential legislative core for all European member states to guarantee the 
protection of human rights regarding biology, medicine and healthcare is the ‘Convention for 
the Protection of Human Rights and Dignity of the Human Being about the Application of 
Biology and Medicine’ 66 and its additional protocol 67. This legislative document 
recommended that “Where, according to law, an adult does not have the capacity to consent to 
an intervention because of a mental disability, a disease or for similar reasons, the intervention 
may only be carried out with the authorization of his or her representative or an authority or a 
person or body provided for by law.” 66. 
Nevertheless, ethical issues remain unresolved even if healthcare professionals including the 
nurse take the surrogate role as they need to identify the which extent therapeutic interventions 
for patient care can be performed 68. The nurse is obliged to collect all types of data from the 
patient including verbal and nonverbal clues as well as consider vital signs and symptoms to 
find how he/she can meet the patients’ physical and psychological needs before making the 
decision on the administration of PRN medications 69. The patient’s behaviours should be 
observed and interpreted to decide about the need to the involuntary administration of PRN 
medications to incapacitated patients. However, this could be a challenge to go beyond reported 
symptoms and understand their meanings in order to provide individualised care 70. In this 
respect, the nurse’s personal attitudes, beliefs and knowledge regarding symptoms and 
behavioural clues indicating the need for medication can influence his/her decision to 
administer medications to a great extend 71. 
 
Overriding the patients’ wishes 
A source of moral concerns is to take a paternalistic role and coerce the patient to take PRN 
medications while the agitated patient is unwilling to cooperate and resist taking medications 
72-74. Beauchamp and Childress (2001) define paternalism as “the intentional overriding of one 
person’s known preferences or actions by another person, where the person who overrides 
justifies the action by the goal of benefitting or avoiding harm to the person whose preferences 
or actions are overridden” (p. 178) 56. Paternalism is the sharp end of professional beneficence 
75 and has been suggested to be considered when the patient is severely incapacitated and when 
treatment is in the patient’s best interest 76. However, it is contradictory to the value of 
autonomy and is a source of tension between restraint and freedom, even if it may accompany 
by good intentions in patient care 77. The nurse’s effort to pursue the patient’s autonomy as an 
end state reflects the value given by him/her to paternalism. He/she may act paternalistically 
based on the assumption that his/her actions may allow the patient to have a more autonomous 
life in the future 78.  
It is noted that even if physical force is not applied by the nurse, the persuasion of patients to 
take medications limits the patient’s autonomy 79. In such situations, the use of informal 
coercion as an ‘unpleasant good’ can be considered if it is one part of the nurse’s job description, 
despite inducing negative feelings in the patient and discomfort in the nurse 80-82. Although it 
may create feeling of safety in the patient, it is also associated with some negative consequences 
including the feeling of fear and disempowerment in the nurse. The nurse has the responsibility 
to protect the human rights of patients, and he/she should be aware of situations in which 
informal coercion is used and what its potential adverse psychological effects can be on 
therapeutic relationships 76, 83.  
As a matter of self-determination, disabled and incapacitated patients may decline invasive 
procedures for medication administration compared to less invasive ones such as the oral route 
84. Therefore, there are some clinical situations in which covert medication administration has 
been suggested for those incapacitated patients who refuse taking medications but indicate a 
high risk of self-harm 85. Nevertheless, complex clinical and ethical issues appear when covert 
medication administration is used 86, as it can damage the relationship between the patient and 
the family member, with the nurse.  
Patients have the right to refuse medications unless there is a court order obligating them to 
take the medication or in emergency situations and only for a limited duration. This is a change 
from previous practices in which those patients who have been involuntarily hospitalized does 
not have decision-making capacity and is considered unable to refuse any kind of medication. 
In this difficult ethical situation, the nurse should face the problem of balancing their own level 
of control over decision making with the preferences of incapacitated patients 87. Therefore, the 
nurse has the responsibility to assess the situation objectively and document the medication 
process to avoid forthcoming legal and ethical issues 81, 88.  
An argument in favour of paternalism emphasizes the utilitarian principle in which decisions 
for the administration of PRN medications may be taken because of the control of patients’ 
behaviour to benefit other people than the patient him/herself. Roberts (2004) 89 affirms that in 
case of illnesses leading to severe incapacity, paternalism will be exercised by the means of 
interventions aiming at the alleviation of human suffering for those afflicted with that illness. 
From an opposing perspective, the negative consequences of forced and involuntary 
administration of medication may include further detachment from therapeutic measures that 
can lead to a violent outbreak requiring the use of restraints and seclusion 90, 91 to gain control 
over the patient's threatening behaviours.  
How the nurse responds to an ethical situation is influenced by his/her understanding of the 
illness. If mental illness is considered a ‘bodily disease’, medications will be seen beneficial for 
avoiding human suffering. On the other hand, if the mental illness is understood as a deviation 
from the culture’s values and norms, a paternalistic medical intervention becomes a political 
act rather than a caring one 89.  
Paternalistic culture-bound preferences should not affect patient care. Each patient must be 
approached impartially addressing their needs, values, and beliefs. Ethical principles and the 
requirement for best available care apply regardless of ethnic, cultural, and religious 
background, even if the patient is incapacitated. A summary of key ethical factors surrounding 
PRN medication administration has been presented in figure 1. 
Figure 1. Ethical factors affecting PRN medication administration 
Implications for clinical practice 
Nurses have the required knowledge and clinical expertise to help with relieving physical and 
psychological suffering among patients 92, and the administration of PRN medications allows 
nurses to become more actively involved in medicines management initiatives in the 
multidisciplinary environment of health care 93. The requirement for the safe administration of 
PRN medications by nurses to incapacitated patients is to comply with regulatory, professional, 
ethical and legal frameworks that govern it to establish a caring environment in which the 
human rights, dignity, values, custom, and spiritual beliefs of the patients are all respected 94. 
A summary of ethical considerations of the administration of PRN medications to incapacitated 




Table 1. PRN medication administration and strategies to avoid unethical practice 
Ethical considerations Practical strategy for the administration of PRN medications 
Patient’s autonomy and right 
of treatment refusal 
Seeking partnership with the family surrogate who can help with the interpretation of 
the patient’s behaviours and prediction of his/her preferences;  
Incorporation of the patient’s wishes and interests into the decision for medication 
administration; 
Prediction of the impact of the decision on the patient’s care outcomes;  
Consideration of clinical guidelines and practical directives to manage difficult 
situations;  
Approaching the physician, ethics committee, guardian or an authority endorsed by 
the law; 
Surrogacy role Observation and interpretation of the patient’s verbal and nonverbal behavioural 
clues; 
Taking vital signs and assessment of symptoms indicating physical and 
psychological suffering;  
Self-reflection on personal attitudes and beliefs regarding the interpretation of the 
patient's symptoms and behaviours; 
Improvement of knowledge through education regarding how to identify the patient's 
need to medications 
Paternalism and patient 
coercion 
Use of enforcement and covert administration of PRN medications only in case that it 
is in the patient’s best interest and can prevent further harm to the patient and others; 
Establishment of coercing interventions on the job description and with the 
consideration of legal aspects; 
Revision of personal beliefs justifying the use of coercion through peer discussion 
and seeking leadership support; 
Exploration of the negative consequences of coercion and covert medications for the 
therapeutic relationship between the nurse and family members; 
Prioritising the use of less invasive methods of medication administration;  
Seeking the legal and court order to justify the duration and possibility of medication 
use; 
Creation of balance between the patient’s preferences and the nurse’s control; 
Objective assessment and documentation of the decision-making process; 
Being impartial for the assessment of the patient’s needs, beliefs, and values 
 
Conclusion   
The administration of PRN medications to incapacitated patients creates a complicated caring 
situation for the nurse and is intertwined with ethical issues affecting the consideration of the 
patient’s wishes and interventions that override them. The patient’s right of autonomy and 
treatment refusal, surrogacy role, paternalism, and coercion are the main ethos of ethical PRN 
medication administration. Education and training can help nurses avoid legal and ethical issues 
in PRN medicines management and improve the quality and safety of health care.  
The improvement of the nurses’ attitudes regarding the ethical considerations of PRN 
medication administration and their application to clinical practice requires discussion and 
reflection by nurses, multidisciplinary collaboration, and leadership support. 
Healthcare organisations can heed such an exchange of ideas by introducing supervision or 
more informal discussion rounds.  
It is also suggested to incorporate these ethical aspects into clinical guidelines and directives 
for the safe administration of PRN medications to incapacitated patients. Also, extra efforts 
should be made by the nurse to evaluate the effectiveness of medication and the possibility of 
harm, as well as detect the possible side effects of medications and adverse drug reactions, 
given the inability of incapacitated patients to report them.  
Emperical research is needed to explore more the interconnection between the administration 
of PRN medications and ethics in the multidisciplinary environment. Also, there is a need to 
conduct experimental studies to investigate how the ethical aspects and principles of PRN 
medicines management can improve the quality and safety of health care.  
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